Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19 is a research paper published in Antioxidants (2020). On theSindex it has a DataRank of 0. It has been cited 109 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: 1R43AG053128
NCI NIH HHS
Grant: P30 CA046934
NIA NIH HHS
Grant: R43 AG053128
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 1R43AG053128-01A1
Supporting Healthy Aging with a Phytochemical Combination that Acts at Multiple Control Points in the Nrf2 Activation Pathway
Fields of Study
Keywords
Sustainable Development Goals